fda novavax - Search News

Order byBest matchMost fresh

FDA, COVID-19 vaccine and Novavax

FDA gives Covid vaccine manufacturers instructions for next fall’s shot

The Food and Drug Administration gave Covid vaccine manufacturers instructions on what next fall’s Covid vaccines should target on Thursday, signaling it would prefer that they update the strain in t...

STAT · 14h

· 6d · on MSN

FDA approves Novavax COVID-19 shot but with unusual restrictions

· 6d · on MSN

After delay, FDA approves Novavax’s Covid-19 vaccine, but only for older people and those at high risk

The FDA plans to limit access to covid vaccines. Here’s why that’s not all bad.

Covid vaccines will soon be required to go through more rigorous trials to ensure that they really are beneficial for people who aren’t at high risk.

MIT Technology Review · 22h

· 1d

FDA panel recommends keeping COVID shots targeted to same strain as last year

Alaska Dispatch News · 21h

Opinion: The FDA’s new covid vaccine policy is clear as mud

US FDA Advisers to Weigh Composition of COVID Vaccines for 2025-2026

Public health experts say that there is no certainty on which strains are going to be dominant.

· 1d

With vaccine approval process set to change, FDA advisers leave wiggle room in annual Covid-19 shot recommendations

· 1d

FDA panel debates COVID vaccine recipe as questions swirl about fall shots

Novavax: Nuvaxovid FDA Approval Unlocks Several Bullish Stimuli

Novavax's full FDA approval for NUVAXOVID is a transformative milestone, unlocking a $175M Sanofi payment and validating their protein-based vaccine technology. The approval positions Novavax as the only non-mRNA COVID-19 vaccine with full FDA approval, offering a differentiated alternative amid growing mRNA fatigue.

Medical Marketing & Media20h

Rx Rundown: BioMarin, Novavax, CellCentric and more

CRISPR Therapeutics announced an agreement with Sirius Therapeutics to develop and commercialize small interfering RNA (siRNA) therapies. Under the deal, CRISPR will pay $25 million in cash and $70 million in equity to Sirius upfront.

1don MSN

Trump’s FDA just changed COVID vaccine rules for 2025 — will you still qualify for boosters under the new guidelines?

FDA COVID vaccine update is stirring major public attention as a new policy limits fall COVID-19 booster shots to seniors and high-risk individuals. While the FDA met to decide if vaccine formulas should change for fall 2025,

19h

FDA advisers recommend updating COVID shots to JN.1 strain

Moderna (MRNA), and Novavax (NVAX) agree as the FDA advisors recommend targeting JN.1 strain for updated COVID vaccines this fall. Read more here.

4don MSN

RFK Jr. pledged not to upend US vaccine system, but big changes are underway

WASHINGTON — Robert F. Kennedy Jr. clinched the political support needed to become the nation’s top health official by pledging to work within the decades-old federal system for approval and use of vaccines. Yet his regulators are promising big changes that cloud the outlook for what shots might even be available.